See the DrugPatentWatch profile for airduo
What Type of Inhaler Is AirDuo RespiClick?
AirDuo RespiClick is a dry powder inhaler (DPI). It delivers a fixed-dose combination of fluticasone propionate (steroid) and salmeterol (long-acting beta agonist) as a breath-actuated dry powder, without propellants or liquid aerosols.[1]
How Does It Work Compared to Metered-Dose Inhalers?
Unlike metered-dose inhalers (MDIs), which use propellants to create a fine aerosol mist that patients coordinate with inhalation, AirDuo RespiClick relies on the patient's breath to draw powder from a capsule-free blister pack. No hand-breath coordination or spacer is needed, making it suitable for patients with poor timing.[1][2]
Why Choose Dry Powder over Aerosol for Asthma or COPD?
Dry powder inhalers like AirDuo RespiClick deposit medication deeper in the lungs due to higher velocity from patient-generated airflow, potentially improving efficacy for maintenance therapy. They avoid chlorofluorocarbon (CFC) or hydrofluoroalkane (HFA) propellants found in aerosols, appealing to environmentally conscious users, though they require stronger inhalation effort.[2]
Common Patient Questions on Usage and Cleaning
Patients often ask if shaking is required—no, as it's not an aerosol. Prime by inhaling sharply through the mouthpiece until a click and whir sound confirm activation. Clean the mouthpiece weekly with a dry wipe; water can clump the powder.[1]
Availability, Dosage, and Alternatives
AirDuo RespiClick comes in 55/14 mcg or 113/14 mcg strengths per inhalation, approved for asthma in patients 12+. It's discontinued in some markets but generics like fluticasone-salmeterol DPI exist. Alternatives include Advair Diskus (another DPI) or aerosol versions like Advair HFA.[1][3]
[1]: FDA Label for AirDuo RespiClick
[2]: American Thoracic Society DPI Guidelines
[3]: Drugs.com - AirDuo RespiClick